Pliant Therapeutics (PLRX) Competitor Comparison
We are evaluating the key criteria listed to compare Pliant Therapeutics (PLRX) against its competitors in the Biotechnology industry.
Market Capitalization
125 / 368Gross Profits
101 / 278Total Revenue
212 / 300EBITDA
268 / 337Free Cashflow
246 / 352Quick Ratio
27 / 357Earnings per Share
260 / 359Dividend yield
0 / 6Total Cash
59 / 358Performance 3 years
112 / 368Performance 5 years
169 / 368Performance 10 years
140 / 368Linearity 3 years
14 / 368Linearity 5 years
75 / 368Linearity 10 years
70 / 368Total Rank
227 / 368Dividend Rank
235 / 368Valuation Rank
260 / 368Piotroski Rank
207 / 368Muliplier Rank
178 / 368Market Capitalization - PLRX ranking 125 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.